vidarabine has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alimoghaddam, K; Badalzadeh, M; Fazlollahi, MR; Ghavamzadeh, A; Hamidieh, AA; Mahdaviani, SA; Pourpak, Z; Setarehdan, SA; Souri, M; Tajik, S; Vaezi, M | 1 |
| Bednarski, JJ; Bhatt, ST; Hente, M; Murray, L; Schulz, G; Shenoy, S; Slater, A | 1 |
| Kapoor, R; Rastogi, N; Yadav, SP | 1 |
| Ahmad, I; Albert, MH; Belohradsky, BH; Bredius, R; Fasth, A; Fernandes, JF; Fischer, A; Gaspar, HB; Gennery, A; Gruhn, B; Güngör, T; Haddad, E; Hassan, M; Hough, R; Kentouche, K; Lachance, S; Moshous, D; Rentsch, K; Resnick, IB; Schanz, U; Schlegel, PG; Seger, R; Shaw, PJ; Slatter, M; Stepensky, P; Stussi, G; Teira, P; Telles da Cunha, JM; Vermont, C; Veys, P | 1 |
| Bunin, N; Heimall, J; Morsheimer, M; Oshrine, B | 1 |
| Abdel-Azim, H; Kapoor, N; Mahadeo, K; Mehta, B | 1 |
| Benninghoff, U; Debatin, KM; Friedrich, W; Gatz, S; Hoenig, M; Schuetz, C; Schulz, A; Speth, F | 1 |
| Albert, MH; Belohradsky, BH; Ehl, S; Freudenberg, F; Güngör, T; Koletzko, S; Prell, C; Roesen-Wolff, A; Roesler, J; Roos, D; Seger, R; Strahm, B; Tommasini, A; Ventura, A; Wintergerst, U | 1 |
| Balasubramanian, A; Bambach, BJ; Bennett, RR; Darras, BT; Estrella, E; Gussoni, E; Kang, PB; Kunkel, LM; Kurtzberg, J; Lidov, HG; Mitchell, M; Shapiro, FD; White, AJ | 1 |
| Belohradsky, BH; Blanche, S; Bordigoni, P; Cant, A; Di Bartolomeo, P; Fischer, A; Flood, T; Gungor, T; Landais, P; Müller, S; Nagler, A; Ozsahin, H; Passwell, JH; Porta, F; Seger, RA; Slavin, S; Wulffraat, N; Zintl, F | 1 |
| Fujiwara, T; Harigae, H; Ishizawa, K; Kameoka, J; Minegishi, M; Miyamura, K; Sasaki, T; Tomiya, Y; Tsuchiya, S; Yamada, M | 1 |
| Fukushima, M; Hasegawa, D; Hosokawa, Y; Kawasaki, K; Kosaka, Y; Mizukami, T; Morio, T; Nunoi, H; Ochiai, H; Takeda, H | 1 |
2 review(s) available for vidarabine and Autosomal Recessive Chronic Granulomatous Disease
| Article | Year |
|---|---|
A fludarabine and melphalan reduced-intensity conditioning regimen for HSCT in fifteen chronic granulomatous disease patients and a literature review.
Topics: Adult; Child; Graft vs Host Disease; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Transplantation Conditioning; Vidarabine | 2022 |
Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antilymphocyte Serum; Bone Marrow; Busulfan; Cause of Death; Child; Child, Preschool; Cyclophosphamide; Europe; Female; Genetic Heterogeneity; Graft vs Host Disease; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Infections; Inflammation; Male; Melphalan; Neutrophils; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2002 |
2 trial(s) available for vidarabine and Autosomal Recessive Chronic Granulomatous Disease
| Article | Year |
|---|---|
A single-center experience using alemtuzumab, fludarabine, melphalan, and thiotepa as conditioning for transplantation in pediatric patients with chronic granulomatous disease.
Topics: Alemtuzumab; Child; Child, Preschool; Follow-Up Studies; Graft vs Host Disease; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Infant; Melphalan; Myeloablative Agonists; Prognosis; Prospective Studies; Thiotepa; Transplantation Conditioning; Vidarabine | 2020 |
Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Busulfan; Child; Child, Preschool; Drug Therapy, Combination; Graft Survival; Graft vs Host Disease; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Prospective Studies; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome; Vidarabine; Young Adult | 2014 |
8 other study(ies) available for vidarabine and Autosomal Recessive Chronic Granulomatous Disease
| Article | Year |
|---|---|
Haploidentical Stem Cell Transplant With Post Transplant Cyclophosphamide for Chronic Granulomatous Disease With Thiotepa, Busulfan, and Fludarabine as Conditioning.
Topics: Antineoplastic Agents; Busulfan; Child, Preschool; Cyclophosphamide; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Thiotepa; Transplantation Conditioning; Transplantation, Haploidentical; Vidarabine | 2021 |
Reduced-intensity conditioning for hematopoietic cell transplantation of chronic granulomatous disease.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Busulfan; Child, Preschool; Graft vs Host Disease; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Transplantation Conditioning; Vidarabine | 2015 |
Low-dose total-body irradiation and alemtuzumab-based reduced-intensity conditioning regimen results in durable engraftment and correction of clinical disease among children with chronic granulomatous disease.
Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Child; Child, Preschool; Chimerism; Graft Survival; Graft vs Host Disease; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Transplantation Conditioning; Unrelated Donors; Vidarabine; Whole-Body Irradiation | 2015 |
Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease.
Topics: Adolescent; Busulfan; Child; Child, Preschool; Chimerism; Cyclophosphamide; Follow-Up Studies; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Kaplan-Meier Estimate; Male; Melphalan; Postoperative Complications; Pulmonary Aspergillosis; Retrospective Studies; Treatment Outcome; Vidarabine; Young Adult | 2009 |
Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease.
Topics: Age of Onset; Anti-Bacterial Agents; Antibodies, Monoclonal; Child; Drug Therapy, Combination; Gene Deletion; Granulomatous Disease, Chronic; Humans; Inflammatory Bowel Diseases; Male; NADPH Oxidases; Steroids; Treatment Outcome; Vidarabine | 2010 |
Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Child; Chromosome Mapping; Chromosomes, Human, X; Cyclophosphamide; Dystrophin; Follow-Up Studies; Gene Deletion; Gene Expression Regulation; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Male; Muscular Dystrophy, Duchenne; Reoperation; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2010 |
Fludarabine- and cyclophosphamide-based nonmyeloablative conditioning regimen for transplantation of chronic granulomatous disease: possible correlation with prolonged pure red cell aplasia.
Topics: ABO Blood-Group System; Adolescent; Blood Group Incompatibility; Cyclophosphamide; Graft Survival; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Male; Neutrophils; Red-Cell Aplasia, Pure; Siblings; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2004 |
Successful treatment of chronic granulomatous disease with fludarabine-based reduced-intensity conditioning and unrelated bone marrow transplantation.
Topics: Bone Marrow Transplantation; Child, Preschool; Cyclophosphamide; Granulomatous Disease, Chronic; Humans; Male; Myeloablative Agonists; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2008 |